Pharmacokinetic Results Of a Feasibility and Phase II Study (ITCC 021) On Bortezomib (BTZ) In Pediatric Relapsed ALL: Lack Of Significant Penetration Of BTZ In The Cerebrospinal Fluid
| Title: | Pharmacokinetic Results Of a Feasibility and Phase II Study (ITCC 021) On Bortezomib (BTZ) In Pediatric Relapsed ALL: Lack Of Significant Penetration Of BTZ In The Cerebrospinal Fluid |
|---|---|
| Authors: | Kaspers, Gertjan, Mathot, Ron *, Ramnarain, Satianand *, Niewerth, Denise *, Locatelli, Franco, De Bont, Eveline S.J.M, Fagioli, Franca *, Rohrlich, Pierre *, von Stackelberg, Arend, Zwaan, Michel |
| Source: | In Blood 15 November 2013 122(21):1439-1439 |
| Database: | ScienceDirect |
Be the first to leave a comment!